drugset / Trial / NCT00649649

Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg

NCT00649649

Phase 1 Completed 24 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan quinapril hydrochloride 40 mg tablets compared to Parke-Davis Accupril® 40 mg tablets following a single, oral 40 mg (1 x 40 mg) dose under fed conditions.

Timeline

Start
2002-12
Primary completion
2002-12
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinapril Small molecule 40 mg Oral

Indications

No indication recorded.